Key result
Alexithymia was more prevalent in patients with chronic lung diseases compared to those with chronic heart diseases.
Why the study?
Alexithymia is a possible risk factor for disease onset and treatment, but its presence and dependence in patients with chronic lung versus heart diseases needed evaluation.
Is alexithymia more prevalent in patients with chronic lung diseases compared to those with chronic heart diseases?
Cross-Sectional (n=100)
No
Is alexithymia more prevalent in patients with chronic lung diseases compared to those with chronic heart diseases?
Alexithymia is significantly more prevalent in patients with chronic lung diseases compared to those with chronic heart diseases.
Answers are grounded in this paper and cite their sources.
Alexithymia may be more prevalent in chronic lung than heart disease; leaves open whether screening or support should differ by condition.
Alexithymia is manifested by limited abilities to identify and express emotions and is a possible risk factor for the onset and treatment of the disease. To determine the dependence of the presence of alexithymia in patients with chronic lung and heart diseases. One hundred respondents aged 35 to 75 participated in the research, 50% of whom were being treated for chronic lung diseases, and 50% for chronic heart diseases. After filling out the Toronto Twenty-Point Scale (TAS-20) questionnaire, the degree of alexithymia was determined. Using the Chi-square test for independence, it was determined that the presence of alexithymia and chronic heart and lung diseases were dependent characteristics (p > 0.0005), and a significantly larger number of respondents with established alexithymia were treated for chronic lung diseases. Using the Chi-square test, it was shown that the presence of alexithymia and the gender of the subject were not dependent characteristics, while the non-parametric Mann-Whitney U test of significance was used to analyze the dependence of alexithymia and the age of the subject. It demonstrated that there was a statistically significant difference in the age of the subjects with and without alexithymia (p < 0.05). In this paper, we found that alexithymia is a more significant risk factor for the occurrence of chronic impairment of lung function in relation to heart disease.
No takes yet. Share an insight, caveat, or question.
Marija Lazarević (2022) conducted a cross-sectional in Chronic lung and heart diseases (n=100). Chronic lung diseases vs. Chronic heart diseases was evaluated on Presence of alexithymia (p=<0.001). Alexithymia was more prevalent in patients with chronic lung diseases compared to those with chronic heart diseases.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: